Severe Hypoglycemia was recorded in two of our patients at ADC (AbouSeifien Diabetes Center) treated by Dulaglutide 1.5 weekly with small doses of Meglitides and the hypoglycemic episode lasted for 3 consecutive days
5.3 Overcoming the bloodbrain barrier (BBB): nanocarrier-based drug delivery The BBB severely restricts CNS penetration of most therapeutic agents
One wants you to eat everything in sight, while the other is like were good after three bites. For many people, the munchies do not disappear completely, but they feel shorter, less intense, or more selective
In 2009, the first glucagon and GLP-1 receptor co-agonist was reported, which combined action profiles of two gastrointestinal hormones within a single molecule achieving a synergistic glucose-lowering and weight loss benefit
Por otro lado, dos medicamentos del mismo grupo teraputico que se indicaban como alternativa han cesado su comercializacin: Byetta y Lyxumia